The House Oversight Committee has asked for a private meeting with executives from the pharmaceutical company Mylan, which is facing a public outcry over the price of a lifesaving allergy injection.
Known by the brand name EpiPen, the device now retails for roughly $600 per two-pack. In 2007, the year Mylan acquired the drug, it cost $100 per pack.
Read Full Article »